The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Undergoing Infertility Treatment
Recruiting · NCT07308561 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
Infertility affects approximately one in six individuals worldwide and is associated with significant psychological distress, particularly among women undergoing treatment. Increased anxiety levels are strongly linked to reduced quality of life during the infertility process. With the growing integration of artificial intelligence (AI) into healthcare, AI-based tools are increasingly used in infertility care to support decision-making and patient engagement. While many patients are familiar with AI technologies, individual attitudes toward AI may influence their acceptance and potential psychosocial benefits. This study aims to examine the relationship between attitudes toward artificial intelligence, anxiety levels, and quality of life among women undergoing infertility treatment.
Who can take part
Inclusion criteria
- Women aged 18-45 years diagnosed with infertility (primary or secondary infertility).
- Women undergoing infertility treatment and those who have experienced various treatment modalities (IUI, IVF, ICSI).
- Women who voluntarily agree to participate in the study.
- Women who are able to understand and speak Turkish.
Exclusion criteria
- Women with diagnosed psychological disorders (e.g., clinical depression, anxiety disorders).
- Women who are not undergoing infertility treatment.
Where it is running
1 location listed.
- Acıbadem Health Group - Istanbul, Ataşehir, Turkey (Türkiye)